LONDON - Global law firm Reed Smith today announced the addition of Milan Thakker as a life sciences transactional partner in its Global Corporate Group. His broad practice centres around cross-border M&A, private equity, venture capital and joint ventures.

Related Professionals: Milan Thakker

Milan joins Reed Smith in London after spending over seven years in the Group Legal Transactions team at the Swiss headquarters of Novartis, where he managed some of the pharma giant’s most notable strategic transactions. Prior to joining Novartis, he specialised in cross-border M&A, private equity, venture capital and corporate law at Shearman & Sterling in London, and at Stephenson Harwood in London and Hong Kong. Whilst in private practice, he also spent time on secondment at a venture capital firm in West London.
Delphine Currie, co-chair of Reed Smith’s Global Corporate Group, commented:

“Milan has acted for a broad spectrum of clients across a number of industries while in private practice, but he has naturally developed a particular expertise and sectoral focus in life sciences during his time at Novartis, and these capabilities will greatly complement our existing corporate and life sciences offering.

We’re delighted that Milan is returning to private practice and we’re looking forward to welcoming him into Reed Smith. He is well known in the life sciences and pharmaceutical industries and I have no doubt he will be a great addition to the team and our clients.”

Milan’s arrival will expand and strengthen Reed Smith’s corporate practice, particularly in the life sciences sector. Whilst qualified to practice in England and Wales, Milan has significant experience advising and leading on deals across a number of jurisdictions, including New York and Delaware.